Randomized Trial for Mixed Acute Rejection
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Alemtuzumab + Rituximab Consolidation in CLL
- Status
- TERMINATED
- Phase
- PHASE2
A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP)
- Status
- COMPLETED
- Phase
- PHASE3
S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Rituximab as Treatment of Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Frontline Treatment With Bendamustine in Combination With Rituximab in Adults Age 65 or Older With Chronic Lymphocytic Leukemia (CLL)
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy Study of Two Treatments in the Remission of Vasculitis
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab, Bortezomib,Bendamustine , Dexamethasone, Patients With Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL
- Status
- COMPLETED
- Phase
- PHASE2
Pegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1